MK-677 training-claim check for a sports medicine or anti-doping conversation

Your situation

Claims with no direct ibutamoren trial identified

Tick each claim you were given. None of these was established by a controlled ibutamoren trial.

• Faster post-exercise recovery or less soreness
• Higher one-repetition maximum, sprint power or endurance
• Faster tendon, ligament or muscle-injury healing
• A pre-workout, post-workout or bedtime advantage
• A training cycle, deload schedule or nutrition protocol
• Safety during high-volume or high-intensity training

What the published human data do say

• In healthy adults aged 60 to 81, a year of MK-677 raised fat-free mass but did not change strength or function.[1]
• Body weight rose 2.7 kg on MK-677 versus 0.8 kg on placebo over that year, so a heavier scale reading is not proof of stronger muscle.[1]
• The trial's own authors judged it too small and short to evaluate function.[1]
• Across studies, FDA's review lists high blood sugar, raised liver enzymes, headache, musculoskeletal complaints, fluid retention and increased appetite among common adverse events.[2]
• FDA describes most ibutamoren clinical data as small, short and without clinically meaningful benefit shown.[2]

Questions to ask

1. Does the rule that applies to my sport list ibutamoren, and how do I confirm that for my organization today?
2. Which result would show a real effect for me: strength, power, recovery time, or only body weight?
3. Given the glucose and fluid findings in trials, what should I report, and to whom?
4. How could I know whether the product contains what the label says?
5. Is there a registered trial I could join instead of using an unapproved product?